Corcept Therapeutics Inc logo

CORT - Corcept Therapeutics Inc News Story

$17.85 0.0  0.0%

Last Trade - 23/10/20

Sector
Healthcare
Size
Mid Cap
Market Cap £1.58bn
Enterprise Value £1.27bn
Revenue £269.3m
Position in Universe 1844th / 6447

BRIEF-Corcept Therapeutics Announces Second Quarter 2020 Financial Results And Provides Corporate Update

Tue 4th August, 2020 10:03pm
Aug 4 (Reuters) - Corcept Therapeutics Inc  CORT.O :
    * CORCEPT THERAPEUTICS ANNOUNCES SECOND QUARTER
2020 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * Q2 NON-GAAP EARNINGS PER SHARE $0.32
    * Q2 GAAP EARNINGS PER SHARE $0.23
    * Q2 REVENUE $88.6 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$90.1
MILLION
    * SEES Q2 REVENUE $88.6 MILLION
    * Q2 EARNINGS PER SHARE ESTIMATE $0.22 -- REFINITIV IBES
DATA
    * REAFFIRMED 2020 REVENUE GUIDANCE OF $355 - 375 MILLION
    * FY2021 EARNINGS PER SHARE VIEW $0.67, REVENUE VIEW $361.0
MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXb4phjL 
Further company coverage:  CORT.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.